Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2026 May 22;64(6):e01324-25. doi: 10.1128/jcm.01324-25

Up-to-date MALDI-TOF MS-based identification of the Corynebacterium diphtheriae species complex for improved diagnostics

Jörg Rau 1,✉, Anja Berger 2, Alexandra Dangel 3, Martin Dyk 1, Tobias Eisenberg 4, Ekkehard Hiller 1, Christiane Hoffmann 5, Peter Kutzer 6, An Martel 7, Andreas Sing 2, Reinhard Sting 1,8
Editor: Barbara A Byrne9
PMCID: PMC13251421  PMID: 42171534

ABSTRACT

The Corynebacterium (C.) diphtheriae species complex (CdSC) comprises the closely related pathogenic species C. diphtheriae, C. belfantii, C. rouxii, C. ulcerans, C. silvaticum, C. ramonii, and C. pseudotuberculosis according to the taxonomic revisions after 2018. Due to their close relationship, reliable species identification within the CdSC is also challenging using MALDI-TOF mass spectrometry (MS) for fast and reliable identification of bacteria. This is relevant for human and veterinary medicine. However, the Bruker MALDI-Biotyper (MBT), a commonly used MALDI-TOF MS system, does not reflect the current CdSC taxonomy, which includes C. belfantii, C. ramonii, C. rouxii, and C. silvaticum as additional Corynebacterium species in the CdSC. Therefore, the objective of the present study is to expand the commercial Bruker database version K (MBTK) in order to achieve reliable identification for all currently known Corynebacterium species within the CdSC. Furthermore, the database expansions were verified with a systematic formal validation procedure in accordance with the German guideline for species identification by MALDI-TOF MS. For this, 328 spectra made from 321 strains including all seven valid species of the CdSC were identified using the MBTK database and a customer-supplemented modified MBTK database. This custom database version included 33 reference spectra of the CdSC covering all member species. The results of the formal validations for both the commercial and the extended database, combined partly with a single signal analysis, provide a substantiated basis for the identification of bacteria of the CdSC. A key element for a fast up-to-date identification has been the exchange of user-generated sets of main spectrum profiles (MSPs) on the open access MALDI User Platform (MALDI-UP) catalog.

IMPORTANCE

Bacteria belonging to the Corynebacterium (C.) diphtheriae complex are relevant pathogens for humans and animals with zoonotic potential. Identification of the novel species of this complex described since 2018, that is, C. belfantii, C. rouxii, C. ramonii, and C. silvaticum, is possible using the widely approved MALDI-TOF mass spectrometry. This is important for targeted therapies, preventive measures, and epidemiological studies. Precise species identification has been achieved by using a supplemented Bruker MALDI reference database. Comprehensive validation of database entries meets the requirements for accurate pathogen identification in accordance with recognized guidelines. This approach to community-driven database expansion and validation is certainly a model for other bacterial species of interest to react to current taxonomic revisions in a short time frame.

KEYWORDS: bacterial identification, MALDI-TOF MS, MALDI-UP, validation, Corynebacterium belfantii, Corynebacterium diphtheriae, Corynebacterium pseudotuberculosis, Corynebacterium ramonii, Corynebacterium rouxii, Corynebacterium silvaticum, Corynebacterium ulcerans

INTRODUCTION

Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) is a widely used technique for the identification of microbial species in routine medical, veterinary, and food microbiology (1–3). This method is based on the comparison of mass spectra obtained from isolates in question with the reference spectra stored in a database. Although commercial databases are well organized with regard to the field of medical microbiology, this is less the case in the area of food and veterinary microbiology. This applies in particular to the zoonotic pathogens of the Corynebacterium (C.) diphtheriae species complex (CdSC), which includes the corynebacterial groups C. diphtheriae sensu lato (s.l.) (C. diphtheriae sensu stricto (s.s.), C. belfantii, C. rouxii), C. ulcerans s.l. (C. ulcerans s.s., C. silvaticum, C. ramonii), and the species C. pseudotuberculosis, which have recently undergone a revision of the species taxonomy. CdSC pathogens cause serious diseases in humans and animals, the most prominent being diphtheria, which is, therefore, subject to a strict disease notification obligation in the EU and, thus requires reliable diagnosis (4–6).

C. diphtheriae (7) is the eponym of the species of the group C. diphtheriae s.l. and the causative agent of classical diphtheria of the upper respiratory tract in humans, a potentially life-threatening, highly transmissible disease (8, 9). However, due to vaccination, classic diphtheria only occurs regionally in Europe (4, 6, 10). Taxonomically, C. diphtheriae has been subdivided into the two subspecies diphtheriae and lausannense (11) and the biovar Belfanti, which has recently been elevated to species rank, C. belfantii (12). A further closely related novel Corynebacterium species is C. rouxii (13), which was formerly assigned to C. belfantii. This species has so far been isolated in the context of skin infections in dogs, cats, and humans (8, 14, 15). To date, nothing is known about its zoonotic potential, so the separation of this species is also particularly relevant for epidemiological investigations.

C. ulcerans (16) has already been identified as a pathogen in humans and in numerous different mammalian taxa including exotic, game, pet, and livestock animals (17–24). In addition to wound infections, C. ulcerans also causes diphtheria-like diseases of the upper respiratory tract in humans and has surpassed the incidence of C. diphtheriae infections in European industrialized nations for several years (4). C. ulcerans infections in humans are mainly acquired through contact with animals, especially cats and dogs, and, thus, represent the most important zoonotic pathogenic agent of the CdSC (18, 25–27). Isolates from wild boars previously classified as C. ulcerans have recently been assigned to the new species C. silvaticum (28). This novel species has been identified as the causative agent of caseous abscesses in wild boars, Iberian pigs, and in one reported case in a roe deer (29–32). Recently, its zoonotic potential has been proven by a few cases of human infections via contact with wild boars (33).

C. ramonii is a further novel zoonotic species of the group of C. ulcerans s.l., which affects humans, dogs, and cats (34–36).

C. pseudotuberculosis (37) is the causative agent of caseous lymphadenitis (CLA), a chronic infection mainly in sheep, goats, and camelids characterized by the formation of abscesses in lymph nodes and internal organs (38–42). The pathogen also causes ulcerative lymphangitis, the so called pigeon fever in horses (43). Isolates originating from water buffaloes are the only isolates known to produce diphtheria toxin and are associated with cases of edematous skin disease (OSD) (44). In general, pseudotuberculosis due to C. pseudotuberculosis is a rare zoonosis, which is transmitted via skin wounds after contact with affected animals (45, 46).

The correct identification of these closely related pathogenic corynebacteria according to the current taxonomy poses a challenge to diagnostics, especially the maintenance of an up-to-date and comprehensive MALDI-TOF MS database. Due to these obstacles, commercial databases usually exhibit a temporal discrepancy in this regard. In the case of species that are relevant to human and animal health, their timely inclusion is of paramount importance. Implementations of user generated solutions are able to close this diagnostic gap. In this context, it is important to emphasize the utmost relevance of quality assurance. The validation concepts that have been developed in accordance with national guidelines have already demonstrated their efficacy in regard to MALDI-TOF MS and Fourier-transform infrared spectroscopy (47–49).

This study aims to expand the database according to the recent taxonomy and intends to perform the formal validation procedure for two databases, the commercial Bruker MALDI Biotyper database version K (MBTK) and an adjusted MBTK database, which was extended with reference spectral entries listed in the MALDI-UP catalog (MBTK*+MUP database). The aim is to achieve reliable identifications of the closely related and recently described taxa of the species of the CdSC and their unequivocal differentiation from non-target bacteria. This procedure might also serve as a model for other scenarios of closely related bacterial species.

MATERIALS AND METHODS

Isolates

The type strains C. belfantii DSM 105776T, C. diphtheriae DSM 44123T, C. pseudotuberculosis DSM 20689T, C. ramonii CIP 112226T, C. rouxii DSM 110354T, and C. ulcerans DSM 46325T were obtained from public strain collections. The type strain of C. silvaticum (CVUAS 4292T = DSM 109167T) was available from the species description and previous studies (28, 29). In addition, the following isolates from publicly available strain collections were included: CIP 102462, CCM 1750, CCM 2823 (assigned as C. ulcerans), DSM 43988, ATCC 13812 = DSM 43989 (C. diphtheriae), and DSM 7177 (C. pseudotuberculosis). In addition to the 13 CdSC strains from public strain collections, further 308 CdSC field isolates were used for the generation of reference spectra and/or for validation purposes (Table S1). From these field isolates, except for one C. diphtheriae sensu stricto (s.s.) isolate from a horse, all utilized diagnostic isolates of C. diphtheriae s.s. (n = 26), and C. belfantii (n = 6) originated from humans and that had been sent to the German National Consiliary Laboratory for Diphtheria (NCLD; LGL Bavaria). Field isolates of C. ulcerans s.s. were obtained from humans (n = 15) and from 10 different animal species (n = 89). The seven C. rouxii isolates were obtained from canids and a hedgehog (14). C. silvaticum isolates (n = 85) were cultured from diseased wild boars and one roe deer (50). Two recent C. silvaticum isolates were of human origin (33). Except for the type strain of C. ramonii, no further assigned isolate of this species was available at the time of the start of this study. For C. pseudotuberculosis, 77 field isolates were included in the study. Three of these were from humans, while 74 isolates were from different ungulates (Table S1).

The human isolates included in this study had been confirmed by the NCLD by MALDI-TOF MS-based species identification (Bruker microflex with MBTK database), a tox gene PCR, followed by an optimized modified ELEK test (51) and a recently published lateral flow diphtheria toxin (DT) immune assay (52), demonstrating DT expression if the tox gene PCR result was positive (53).

Phospholipase D activity (PLD) was demonstrated by the reversed CAMP phenomenon (inhibition of the outer hemolysis zone of an orthogonal growing Staphylococcus aureus isolate and synergistic enhancement of the hemolysis with orthogonal growing Rhodococcus hoagii) (cf. 50, 54).

In order to confirm the species classification of potential C. ramonii isolates, whole-genome DNA sequencing (WGS) was carried out, followed by an average nucleotide identity analysis using PyANI software (v. 0.2.12, https://pyani.readthedocs.io/en/latest/), an open-source python-based tool for calculating Average Nucleotide Identity (ANI). WGS was performed on a NovaSeq 6000 (S4 Reagent Kit v1.5) with 2 × 150 bp paired-end reads subsequent to Nextera XT library preparation (both Illumina, San Diego, USA), using 1 ng of genomic DNA. Library preparation and sequencing were carried out by CeGaT GmbH (Tübingen, Germany). The sequencing data sets were assembled with the AQUAMIS pipeline (55). The genomes were compared to a selection of publicly available reference genomes in the NCBI database (https://www.ncbi.nlm.nih.gov/), downloaded on 04.09.2024. The complete list of sequence data sets used can be found in the appendix (Table S2). These data sets included, for example, the C. pseudotuberculosis reference genome of strain MEX29 (NZ_CP016826.1) as well as C. belfantii FRC0043 (GCF_900205605), C. diphtheriae ISS3319 (NZ_CP025209.1), C. rouxii FRC0190 (NZ_LR738855), C. ulcerans 809 (NC_017317), C. ramonii FRC0011 (GCF_000767685.1), and C. silvaticum PO100/5 (NZ_CP021417). ANIm (MUMmer algorithm) and ANIb (BLASTN+ algorithm) analyses were performed with the help of PyANI as previously described by Hiller et al. (42) (Fig. S1). An ANI match with more than 95% identity to a reference isolate was used to determine the species (56).

For testing the exclusivity of the MALDI-TOF MS method, 1,264 isolates outside the CdSC were used, representing 844 species of 218 genera and including 127 bacterial isolates from other members of the phylum Actinomycetota (Actinobacteria) (57). All individual tests and metadata for the isolates used are depicted in Table S1.

Cultivation and sample preparation

Corynebacteria and other microorganisms belonging to different taxonomic groups were cultivated in accordance with their specific requirements. The individual growth conditions of all bacteria utilized for single spectra acquisitions are accessible through the MALDI-UP (MUP) catalog (58). A selection of these data is presented in Table S1. The ethanol-formate extraction protocol was used for generating MALDI-TOF mass reference spectra as recommended by the manufacturer. In addition, the direct transfer and extended direct transfer protocols were applied to record the set of individual spectra used for validation. These latter simplified protocols correspond to those used in the routine workflow in many laboratories (Table S1) (48, 59, 60). In addition, spectra listed in MUP were included, which were created using a special sample preparation procedure for highly pathogenic bacteria (61).

MALDI-TOF MS Databases

The two databases, MBTK and MBTK*+MUP, were used, and the results were compared.

Commercial MBTK database

The commercial database version K for the Bruker MALDI-Biotyper Compass system (MBTK) was released in 2022 as a “research use only” (RUO) application (Bruker Daltonik, Bremen, Germany). This database is, therefore, not intended for in vitro diagnostic (IVD). The MBTK- database includes 11,897 reference entries, deposited as so called main spectra or main spectra projections (MSP) by the manufacturer, which were derived from 4,320 bacterial species (database product information [62]). In the MBTK database, only three species of the CdSC have been included up to the year 2018: C. diphtheriae, C. ulcerans, and C. pseudotuberculosis. For these entries, no subspecies information has been given by the manufacturer. The names of CdSC-MSPs from the MBTK library entries are listed in Table 1.

TABLE 1.

MALDI-TOF MS reference spectra of Corynebacterium diphtheriae species complex bacteria (CdSC), available in the MALDI Biotyper database version K (MBTK), and additional reference spectra listed on the MALDI User Platform (MUP) used in this studya,b

Species Isolate/strain Reference entry name (MSP) Database source Database
MBTK MBTK*+MUP
C. belfantii DSM 105776T Corynebacterium belfantii DSM 105776 CVUAS MUP 1781 x
KL0171 Corynebacterium belfantii KL0171 CVUAS MUP 1745 x
KL0236 Corynebacterium belfantii KL0236 CVUAS MUP 1746 x
C. diphtheriae DSM 44123T Corynebacterium diphtheriae DSM 44123T DSM_2 MBTK x #
Corynebacterium diphtheriae diphtheriae DSM 44123 CVUAS MUP 6620 x
CCUG 15935 Corynebacterium diphtheriae CCUG 15935 CCUG MBTK x #
CCUG 55537 Corynebacterium diphtheriae CCUG 55537 CCUG MBTK x #
DSM 43988 Corynebacterium diphtheriae DSM 43988 DSM MBTK x #
1G12072319_3e Corynebacterium diphtheriae 1G12072319_3e MVD MBTK x #
44_R9 Corynebacterium diphtheriae 44_R9 ISB MBTK x #
50_R5 Corynebacterium diphtheriae 50_R5 ISB MBTK x #
R1_36_29 Corynebacterium diphtheriae R1_36_29 ISB MBTK x #
KL0163 Corynebacterium diphtheriae gravis KL0163 CVUAS MUP 1747 x
KL0167 Corynebacterium diphtheriae gravis KL0167 CVUAS MUP 1748 x
KL0187 Corynebacterium diphtheriae gravis KL0187 CVUAS MUP 1749 x
KL0232 Corynebacterium diphtheriae gravis KL0232 CVUAS MUP 1750
KL0237 Corynebacterium diphtheriae gravis KL0237 CVUAS MUP 1751 x
KL0240 Corynebacterium diphtheriae gravis KL0240 CVUAS MUP 1752 x
KL0173 Corynebacterium diphtheriae mitis KL0173 CVUAS MUP 1753 x
KL0179 Corynebacterium diphtheriae mitis KL0179 CVUAS MUP 1754 x
KL0235 Corynebacterium diphtheriae mitis KL0235 CVUAS MUP 1755 x
C. pseudotuberculosis
‍
DSM 20689T Corynebacterium pseudotuberculosis DSM 20689T DSM MBTK x x
Corynebacterium pseudotuberculosis Ovis gv ovis DSM 20689 CVUAS MUP 7393 x
59_D6_coll Corynebacterium pseudotuberculosis 59_D6_coll ISB MBTK x x
62_D6_coll Corynebacterium pseudotuberculosis 62_D6_coll ISB MBTK x x
64_D6_coll Corynebacterium pseudotuberculosis 64_D6_coll ISB MBTK x x
GD7 Corynebacterium pseudotuberculosis GD7 GDD MBTK x x
GD8 Corynebacterium pseudotuberculosis GD8 GDD MBTK x x
X x 102968 C Corynebacterium pseudotuberculosis x_x_102968_C IBS MBTK x x
992 Corynebacterium pseudotuberculosis Equi NTTB 992 CVUAS MUP 935 x
CVUAS 32689 Corynebacterium pseudotuberculosis Ovis gv-camelid CVUAS 32689 CVUAS MUP 2398 x
CVUAS 5583,2 Corynebacterium pseudotuberculosis bv Ovis gv-camelid CVUAS 5583.2 CVUAS MUP 958 x
C. ramonii CIP 112226T Corynebacterium ramonii CIP 112226T CVUAS MUP 6614 x
CVUAS 34267 Corynebacterium ramonii CVUAS 34,267 CVUAS MUP 7345 x
C104 Corynebacterium ramonii C104 CVUAS MUP 7346 x
C. rouxii DSM 110354T Corynebacterium rouxii DSM 110354 CVUAS MUP 1782 x
191012535 Corynebacterium rouxii 191012535 CVUAS MUP 1935 x
Corynebacterium rouxii 191012535_LHL-GI MUP 1744 x
211002017-1 Corynebacterium rouxii 211002017-1_LHL-GI MUP 3235 x
211002017-2 Corynebacterium rouxii 211002017-2_LHL-GI MUP 3236 x
C138 Corynebacterium rouxii C138 CVUAS MUP 813
CVUAS 3559,2 Corynebacterium rouxii CVUAS 3559,2 CVUAS MUP 1014 x
KL1306 Corynebacterium rouxii KL 1306 CVUAS MUP 1783
KL1663 Corynebacterium rouxii KL 1663 CVUAS MUP 1901
C. silvaticum CVUAS 4292T = DSM 109166T Corynebacterium silvaticum CVUAS 4292 CVUAS MUP 0083 x
CVUAS 6455 Corynebacterium silvaticum CVUAS 6455 CVUAS MUP 0922 x
C. ulcerans DSM 46325T Corynebacterium ulcerans DSM 46325T DSM MBTK x #
Corynebacterium ulcerans DSM 46325 CVUAS MUP 2212 x
66_D6_coll Corynebacterium ulcerans 66_D6_coll ISB MBTK x #
67_D6_coll Corynebacterium ulcerans 67_D6_coll ISB MBTK x #
71_D6_coll Corynebacterium ulcerans 71_D6_coll ISB MBTK x #
MCW 10006 Corynebacterium ulcerans MCW_10006 MCW MBTK x #
VA22435_07 Corynebacterium ulcerans VA22435_07 ERL MBTK x #
131011719 Corynebacterium ulcerans NT 131011719 CVUAS MUP 1015 x
141001548 Corynebacterium ulcerans NT 141001548 CVUAS MUP 1021 x
07UVF148 Corynebacterium ulcerans 07UVF148 LLBB MUP 0966 x
CVUAS 10306 Corynebacterium ulcerans TTB CVUAS 10306 CVUAS MUP 0945 x
S-477-6-21 Corynebacterium ulcerans S-477-6-21 CVUAS MUP 2339 x
a

MBTK*: Commercial database modified by extraction of entries of unclear assignment with regard to the new species of the CdSC. The extracted commercial reference spectra were marked with (#) in the last row. MUP: Custom made database entries selected from the MALDI-UP catalogue. The MUP catalogue number is given for user made entries. T: type strain; bv: biovar; gv: genomovar.

b

“x” indicates the individual reference entries in the database.

Updated commercial MBTK*+MUP database

In order to be able to identify the new species of the CdSC, a revision of the MBTK database was required. For this purpose, 33 customs made MSPs for all current seven CdSC species were created by three laboratories in order to replace the previous MSPs of C. diphtheriae (s.l.) and C. ulcerans (s.l.) in the commercial reference database. These user-made entries were integrated into the greater MUP database using the project section of the Biotyper Compass Explorer software module (vers. 4.1.100; Bruker) (Table 1). Four further MSPs were used in the dendrogram analysis, made with the cluster tool in the Biotyper Compass Explorer software (Fig. 1). Reference spectra measurements and calculations of MSPs followed the manufacturer’s manual and commentary (60). These procedures have been recently described in more detail (48).

Fig 1.

Dendrogram showing spectral relationships among Corynebacterium diphtheriae complex species from MALDI-TOF analysis. Seven species clusters with strains and biovars arranged hierarchically by spectral similarity with distance scale.

Dendrogram of selected MALDI-TOF reference mass-spectra from all current species of the Corynebacterium diphtheriae species complex, created by MALDI-User Platform users, depicting the spectral relationships of the species. C. freiburgense DSM 45254T was used as an outgroup. The Cluster tool of the Biotyper Compass software was used with the default setting, using distance measures “correlation” and “average linkage”; bv: biovar; gv: genomovar.

Analyses of MBTK MSPs in the MBTK*+MUP database

As the taxonomic species which have been delineated since 2018 have not yet been included in the commercial MBTK database, the MSPs of the MBTK were analyzed only by the MUP database. The results were evaluated using the first two hits obtained, analogous to the evaluation of the individual validation spectra set.

Validation spectra

For validation purposes, a total of 1,609 single MALDI-TOF mass spectra obtained from 1,585 isolates were selected from the spectra listed in the MUP catalog (version 05.03.2025, https://maldi-up.ua-bw.de) [cf. 58]. These individual spectra are raw spectra, as they occur in routine diagnostics. The metadata for all single spectra (cultivation conditions, sample preparation methods, device system, and the creator) are listed in Table S1. Of these spectra set, 457 spectra from 448 isolates belonged to the phylum Actinomycetota, including 328 spectra (321 isolates) from CdSC members. The spectra used originated from pathogenic bacterial species belonging to the phylum Actinomycetota, for example, Actinomyces (n = 5 species), Arcanobacterium (n = 11), Schaalia (n = 5), or other Corynebacterium spp. (n = 37). Further information on every individual spectrum and the custom reference spectra is provided in MUP. This catalog includes metadata of the isolates, like cultivation conditions, and the data basis of species assignment of the isolate (see reference 58; Table S1). Hence, spectra from 17 laboratories were used for the complete set of spectra obtained from MUP.

Validation procedure

The validation procedure has recently been described (48) and follows the guidelines created by the working group MALDI-TOF, pursuant to §64 of the German Food and Feed Code (47, 63). These guidelines, which are used for MALDI-TOF MS species identification in the food sector, have been adopted unchanged for the differentiation of CdSC bacteria. In order to examine the effect of custom-made database additions on the identification results, two databases were compared using the same validation spectra set. The first was the commercial MBTK database, and the second was a modified MBTK, with an exchange of the 14 commercial CdSC reference entries from C. diphtheriae (s.l.) and C. ulcerans (s.l.) with 33 custom-made reference MSPs of the CdSC obtained from MALDI-UP (Table 1). This version of the custom database includes 1,486 user-made entries of a broad number of bacterial species (Table 1).

Identification results were scored according to the manufacturer’s instructions (Bruker). The first result in the list has to yield a score value of at least 2.0, and the second result has to show no contradictory species that exceed a score value of >2.0. This straightforward rule was applied to the same extensive spectra set (n = 1,609) for both database combinations. The detailed results are presented as reports in the Tables S3a through i for the commercial MBTK database and Tables S4a through f for the modified and extended database MBTK*+MUP.

Manual analysis of spectra of C. ulcerans/ C. ramonii

Crestani and colleagues observed a specific MALDI-TOF mass spectrum signal at 5,405.4 m/z distinguishing the newly described species C. ramonii from C. ulcerans s.s. (34). Figure 2 presents overlays of mass spectra from all C. ulcerans s.s. and C. ramonii isolates of this study, confirming the m/z (5,405.4 ± 2.0) window, in which the specific signal of C. ramonii is recognized. Therefore, raw spectra were loaded into the FlexAnalysis program (version 3.4, Bruker) for manual analysis. Baseline correction and smoothing were performed using settings consistent with the MSP preparation procedure (MBT standard method, Bruker). Peak maxima of interest were manually assigned (Fig. 2).

Fig 2.

MALDI-TOF mass spectra showing Corynebacterium ramonii characteristic signal at 5405.4 m/z,with a vertical bar marking the signal range. Spectral lines compare spectra of C. ramonii isolates with spectra from C. ulcerans strains.

Section of the MALDI-TOF mass spectra, ranging from 5,350 to 5,450 m/z, displaying the signal characteristic of Corynebacterium (C.) ramonii at 5,405.4 m/z, as outlined by Crestani et al. (34). Purple: C. ramonii CIP 112226T, blue: spectra of C. ramonii isolates C86, C104, C139, C167, CVUAS 34267, all from hedgehogs, and pale blue and light green: KL3299A and CCM 2825 from humans, red: C. ulcerans DSM 46325T, green: overlay of single spectra of 103 C. ulcerans s.s. isolates (for metadata of the isolates, see Table S1). Baseline correction and smoothing of spectra were performed using settings consistent with the MSP preparation procedure. The bar shows the range of ±2 m/z around the specific signal. T: type strain.

RESULTS AND DISCUSSION

Numerous bacteria are currently facing significant revisions in taxonomy, promoted by a strong increase in data from WGS. Therefore, it is essential to align the widespread and accepted key tool MALDI-TOF MS for rapid and precise routine identification of bacteria to current revisions in order to ensure reliable and up-to-date species level identifications (1–3, 64). However, it must be taken into account that the precision of this tool depends on prompt database updates by the implementation of supplementary or revised reference spectra (48). Another important point is formal validation, which should be done according to accepted guidelines (47). This is particularly the case for microorganisms of medical and veterinary relevance, such as members of the closely related CdSC, whose species differentiation is challenging (12, 13, 28, 34).

The commercial MBTK database

The commercial MALDI Biotyper MBTK database contains reference spectra only for three representatives of the CdSC (n = 21), including entries for the type strains of C. diphtheriae, C. pseudotuberculosis, and C. ulcerans (Table 1). However, the species described since 2018 have not yet been included in this reference data set (Bruker MBTK). Therefore, we created and exchanged 33 custom made reference entries to expand the commercial MBTK database with the aim of improving the species identification accuracy, particularly with regard to C. belfantii, C. ramonii, C. rouxii, and C. silvaticum (Table 1; Fig. 1).

Thus, using the commercial MBTK among the validation spectra set, spectra of the current taxonomic species C. diphtheriae s.s. (n = 31/31), C. belfantii (n = 7/7), and C. rouxii (n = 7/8) yielded consistent score values greater than 2.0 and were consequently supposedly assigned to “C. diphtheriae.” One C. rouxii isolate could not be identified. Considering the current taxonomy, C. belfantii and C. rouxii were not correctly identified as separate species by the MBTK (Table 2).

TABLE 2.

Species identifications of Corynebacterium diphtheriae species complex bacteria samples by MALDI-TOF MS using the commercial Bruker database MBTKc,d

Species/parameter of interest No. of samples Score mean Score STD No. of samples identified Identification rate (%) No. of true positive No. of false negative True positive rate (%) of identified samples False negative rate (%) of identified samples No. of. samples of the control group No. of samples identified Identification rate (%) No. of true negative No. of false positive True negative rate (%) of identified samples False positive rate (%) of identified samples Criteria of the BVL guideline fulfilled
C. diphtheriae s.l.
 C. belfantii 7 2.19 0.09 7 100 0 7a 0 100a 1,602 803 50.1 803 0 100 0 No
 C. diphtheriae s.s. 31 2.41 0.11 31 100 31 0 100 0 1,578 786 49.8 772 14a 98.2 1.8a No
 C. rouxii 8 2.12 0.11 7 87.5 0 7a 0 100a 1,601 803 50.2 803 0 100 0 No
C. diphtheriae s.s., C. belfantii, C. rouxii interpreted as C. diphtheriae s.l. 46 2.33 0.16 45 97.8 45 0 100 0 1,563 772 49.4 772 0 100 0 Yesa
C. pseudotuberculosis 80 2.36 0.17 80 100 80 0 100 0 1,529 723 47.3 723 0 100 0 Yes
C. ulcerans s.l.
 C. silvaticum 88 2.10 0.10 78 88.6 0 78b 0 78b 1,521 803 52.8 803 0 100 0 No
 C. ramonii 9 2.37 0.09 9 100 0 9 0 100b 1,600 803 50.2 803 0 100 0 No
 C. ulcerans s.s. 105 2.37 0.10 105 100 105 0 200 0 1,504 785 52.2 698 87a 88.9 11.1b No
C. ulcerans. s., C. ramonii, C. silvaticum interpreted as C. ulcerans s.l. 202 2.25 0.17 202 100 202 0 100 0 1,485 698 46.7 698 0 100 0 Yesb
a

C. belfantii and C. rouxii are not represented in the database used.

b

C. ramonii and C. silvaticum are not represented in the database used. s.l.: sensu lato; s.s.: sensu stricto, No.: number; Score STD: standard deviation of the score.

c

True/False: the species was correctly/not correctly identified. All samples within the control group did not belong to the parameter of interest. Individual results for every sample are given in Tables S3a through i.

d

Italics indicate calulated values, like %, mean STD, against the counted numbers (roman).

This is also the case for the recently described species C. ramonii which cannot be identified by the current commercial MBTK database (34). The same applies to C. ulcerans and C. silvaticum so that all validation spectra of C. ulcerans s.s. (n = 105), C. silvaticum (n = 88), and C. ramonii (n = 9) were identified as C. ulcerans s.l. by the commercial MBTK database. In contrast, all confirmed C. pseudotuberculosis isolates (n = 80) were correctly identified using the commercial MBTK with a mean score value of >2.0 (Table 2).

In summary, the commercial MBTK only allows allocation to the three “classical” species C. diphtheriae s.l., C. ulcerans s.l., and C. pseudotuberculosis. Nevertheless, no misidentifications with non-CdSC bacteria of the validation data set and no conflicting results were observed.

However, the manufacturer provides the “matching hint” with the commercial MBTK database “Species pseudotuberculosis/ulcerans of the genus Corynebacterium have very similar patterns: Therefore, distinguishing this species is difficult” for C. pseudotuberculosis and C. ulcerans (62). Based on the results of the validation study presented here, the previous matching hint for the MBTK may be replaced more appropriately by an announcement indicating the detection of C. diphtheriae s.l., C. ulcerans s.l., and C. pseudotuberculosis (Table 3).

TABLE 3.

Matching hints of Corynebacterium diphtheriae species complex samples by MALDI-TOF MS for identifications results with the commercial Bruker database MBTKa

Species identified by MBTK Proposed matching hint to avoid misidentification
C. diphtheriae This result should be interpreted as C. diphtheriae s.l., comprising C. diphtheriae s.s., C. belfantii, and C. rouxii
C. pseudotuberculosis No matching hint
C. ulcerans This result should be interpreted as C. ulcerans s.l., comprising C. ulcerans s.s., C. silvaticum, and C. ramonii
a

Utilising solely the commercial MBTK database version, the following matching hints for the identification were proposed. Because of the lack of certain species and respective specific MSPs in the database used, a differentiation within the mentioned sensu lato groups is not applicable.

Corynebacteria not belonging to the CdSC and other species of the phylum Actinomycetota as well as more distantly related bacteria included in the validation set which comprises more than 1,500 individual spectra were clearly separated from the CdSC species using the commercial MBTK database (Table 2).

Identifications of MSPs from the MBTK database using the MUP database

Due to the supposed uncertain species identifications of the members of the CdSC according to the taxonomy after 2018, MSPs for the three classical species C. diphtheriae, C. ulcerans, and C. pseudotuberculosis were extracted from the MBTK and identified using the MUP database. However, the identification results obtained in this way were not always consistent (Table 4). Thus, among the species attributable to C. diphtheriae s.l., seven of eight MSPs showed a matching result for C. diphtheriae s.s., consistent in the first and second hit. In contrast, the MSP “Corynebacterium diphtheriae 44_R9 ISB” was assigned to C. belfantii, a former biovar of C. diphtheriae and yielded scores of 2.4. Similarly, analysis of the six MBTK-MSPs of C. ulcerans s.l. resulted in several hits for the type strain of C. ramonii with a score of ≥2.2 as the first and/or the second hit result (Table 4).

TABLE 4.

Database cross-check using the main spectra projections (MSPs) of the Corynebacterium diphtheriae species complex (CdSC) from the commercial Bruker database MBTK as samples, identified by using only the CdSC-MSPs from the MALDI-UP catalog in order to scrutinize the recent taxonomy (cf. Table 1); bv: biovar; gv: genomovara

Reference entry name (MSP) from MBTK Result with CdSC-MSP from MALDI-UP database
1. hit (score);
2. hit (score)
Corynebacterium diphtheriae DSM 44123T DSM_2 C. diphtheriae gravis KL0240 CVUAS (2.68);
C. diphtheriae gravis KL0167 CVUAS (2.67)
Corynebacterium diphtheriae CCUG 15935 CCUG C. diphtheriae gravis KL0163 CVUAS (2.52);
C. diphtheriae mitis KL0235 CVUAS (2.50)
Corynebacterium diphtheriae CCUG 55537 CCUG C. diphtheriae mitis KL0252 CVUAS (2.60);
C. diphtheriae diphtheriae DSM 44,123 CVUAS (2.59)
Corynebacterium diphtheriae DSM 43988 DSM C. diphtheriae diphtheriae DSM 44123 CVUAS (2.67);
C. diphtheriae gravis KL0163 CVUAS (2.62)
Corynebacterium diphtheriae 1G12072319_3e MVD C. diphtheriae gravis KL0167 CVUAS (2.63);
C. diphtheriae gravis KL0237 CVUAS (2.61)
Corynebacterium diphtheriae 44_R9 ISB C. belfantii DSM 105776 CVUAS (2.41);
C. belfantii KL0171 CVUAS (2.36)
Corynebacterium diphtheriae 50_R5 ISB C. diphtheriae gravis KL0163 CVUAS (2.07);
C. diphtheriae mitis KL0235 CVUAS (2.07)
Corynebacterium diphtheriae R1_36_29 ISB C. diphtheriae diphtheriae DSM 44123 CVUAS (2.56);
C. diphtheriae mitis KL0252 CVUAS (2.52)
Corynebacterium pseudotuberculosis DSM 20689T DSM C. pseudotuberculosis bv Ovis DSM 20689 CVUAS (2.48);
C. pseudotuberculosis bv Equi NTTB 992 CVUAS (2.230)
Corynebacterium pseudotuberculosis 59_D6_coll ISB C. pseudotuberculosis bv Ovis gv-camelid CVUAS 5583.2 CVUAS (2.53);
C. pseudotuberculosis bv Ovis gv-camelid CVUAS 32689 CVUAS (2.47)
Corynebacterium pseudotuberculosis 62_D6_coll ISB C. pseudotuberculosis bv Ovis gv Camelid CVUAS 5583.2 CVUAS (2.36);
C. pseudotuberculosis bv Ovis gv Camelid CVUAS 32689 CVUAS (2.31)
Corynebacterium pseudotuberculosis 64_D6_coll ISB C. pseudotuberculosis bv Ovis gv Camelid CVUAS 5583.2 CVUAS (2.37);
C. pseudotuberculosis bv Ovis DSM 20689 CVUAS (2.29)
Corynebacterium pseudotuberculosis GD7 GDD C. pseudotuberculosis bv Ovis gv Camelid CVUAS 5583.2 CVUAS (2.54);
C. pseudotuberculosis bv Ovis gv Camelid CVUAS 32689 CVUAS (2.47)
Corynebacterium pseudotuberculosis GD8 GDD C. pseudotuberculosis bv Ovis DSM 20689 CVUAS (2.51);
C. pseudotuberculosis bv Ovis gv Camelid CVUAS 5583.2 CVUAS (2.48)
Corynebacterium pseudotuberculosis x_x_102968_C IBS C. pseudotuberculosis bv Ovis DSM 20689 CVUAS (2.24);
C. pseudotuberculosis bv Ovis gv Camelid VUAS 5583.2 CVUAS (2.22)
Corynebacterium ulcerans DSM 46325T DSM C. ramonii CVUAS 34267 CVUAS (2.45);
C. ulcerans NT 131011719 CVUAS (2.32)
Corynebacterium ulcerans 66_D6_coll ISB C. ulcerans NT 141001548 CVUAS (2.12);
C. ulcerans 07UVF148 LLBB (2.12)
Corynebacterium ulcerans 67_D6_coll ISB C. ramonii CVUAS 34267 CVUAS (2.27);
C. ulcerans NT 131011719 CVUAS (2.21)
Corynebacterium ulcerans 71_D6_coll ISB C. ulcerans DSM 46325 CVUAS (2.25);
C. ulcerans NT 141001548 CVUAS (2.21)
Corynebacterium ulcerans MCW_10006 MCW C. ramonii CVUAS 34267 CVUAS (2.64);
C. ramonii CIP 112226 CVUAS (2.61)
Corynebacterium ulcerans VA22435_07 ERL C. ramonii CVUAS 34267 CVUAS (2.41);
C. ramonii CIP 112226 CVUAS (2.38)
a

In bold: divergent results for the MBTK reference spectra.

This cross-check investigation revealed that representatives of the new CdSC species may be masked among the earlier reference entries in the commercial MBTK Bruker database. Thus, MSPs of C. ulcerans (s.l.) and C. diphtheriae (s.l.) were excluded from the commercial MBTK database, in order to eliminate any potential inaccuracies in classification (Table 4). This is mentioned as the “modified” MBTK*.

The single spectra identified as C. ulcerans s.l., using the MBTK database, were examined for the single signal at m/z 5,405.4 described by Crestani et al. (34) as a unique signal marker for C. ramonii (34). In addition to the type strain, seven isolates exhibited a positive signal for this marker (see Fig. 2). The aforementioned conspicuous isolates were subsequently analyzed in detail by whole-genome sequencing (WGS), following the approach described before (42). This analysis assigned the wildlife isolates C86, C104, C139, C167, CVUAS 34267 originating from hedgehogs, and the human isolates KL3299A and CCM 2823 to C. ramonii. Once the isolates mentioned above had been reassigned, the two databases were subsequently validated. In contrast, no conflicting results were identified for the well delimited species C. pseudotuberculosis.

Consequently, an optimized database (MBTK*+MUP database) enriched by novel MSP expansions and a selective subtraction of suboptimal MSPs from the commercial database (MBTK) is used.

The updated commercial database MBTK*+MUP

The custom set of reference spectra from the MUP database (Fig. 1), and the application of the described specific m/z values, for C. ulcerans/C. ramonii, refined and improved the identification results for all CdSC species. Thus, using the MBTK*+MUP database, all spectra from C. diphtheriae s.s. isolates were correctly assigned to the corresponding species (31 out of 31). In comparison to the use of the MBTK database, the mean score for this set of spectra could be increased from 2.19 to 2.45. Isolates reliably assigned to C. belfantii (type strain and several isolates previously identified as C. diphtheriae bv. Belfanti at the NCLD) were correctly identified at the species level with the new database, using the first two hit approach. Furthermore, all C. rouxii spectra (n = 8) were also correctly identified with the MBTK*+MUP database (Table 5). Within C. diphtheriae s.s., biovar information was available only for some isolates, but not for the subspecies. This aspect was, therefore, not investigated.

TABLE 5.

Results of species identification of Corynebacterium diphtheriae species complex samples by MALDI-TOF MS using the modified database (MBTK*+MUP)a,b

Species/parameter of interest No. of samples Score mean Score STD No. of samples identified Identification rate (%) No. of true positive No. of false negative True positive rate (%) of identified samples False negative rate (%) of identified samples Samples of the control group No. of samples identified Identification rate (%) No. of true negative No. of false positive True negative rate (%) of identified samples False positive rate (%) of identified samples Criteria of the BVL guideline fulfilled
C. belfantii 7 2.49 0.16 7 100 7 0 100 0 1,602 1,225 76.5 1,225 0 100 0 No
C. diphtheriae s.s. 31 2.45 0.17 30 100 30 0 100 0 1,578 1,221 77.4 1,221 0 100 0 Yes
C. rouxii 8 2.62 0.15 8 100 8 0 100 0 1,601 1,243 77.6 1,243 0 100 0 No
C. pseudotuberculosis 80 2.46 0.14 80 100 80 0 100 0 1,529 1,171 76.6 1,171 0 100 0 Yes
C. silvaticum 88 2.52 0.12 88 100 88 0 100 0 1,521 1,163 76.5 1,163 0 100 0 Yes
C. ulcerans–C. ramonii 114 2.47 0.10 114 100 114 0 100 0 1,495 1,179 78.9 1,179 0 100 0 Yes
Species decision by single peak analysis (m/z 5,405.4)
C. ramonii 9 9 100 9 0 100 0 105 100 105 0 No
C. ulcerans s.s. 105 105 100 105 0 100 0 9 100 9 0 Yes
a

True/False: the species was correctly/not correctly identified. All samples within the control group did not belong to the parameter of interest. Individual results for every sample are given in Tables S4a through f. s.l.: sensu lato; s.s.: sensu stricto, No.: number; Score STD: standard deviation of the score.

b

Italics indicate calulated values, like %, mean STD, against the counted numbers (roman).

Similarly, all spectra of C. ulcerans s.s. isolated from a broad collection of host species were correctly assigned with the MBTK*+MUP database. The 88 isolates of C. silvaticum, corresponding to the former “wild-boar cluster” of C. ulcerans (50), were also correctly identified and no discrepancies to C. ulcerans or C. ramonii were observed with the modified database. The two species, C. ulcerans s.s. and C. ramonii, were combined in the formal validation step (Table S4f; Table 5). Presently, only the subsequent evaluation of the species-specific m/z value of 5,405.4 for C. ramonii described by Crestani et al. (34) allows a separation from C. ulcerans s.s. All isolates’ spectra showing the respective signal were confirmed as belonging to C. ramonii by WGS analysis (Fig. S1). Remarkably, also strain CCM 2823 (= CIP 54.69) was provisionally assigned to C. ramonii. Due to the small number of available isolates of C. ramonii (n = 9), a formal validation, which requires at least 20 individual spectra for the validation of a targeted identification in the sense of the guideline is pending (47).

Regarding C. pseudotuberculosis, the use of the modified and extended MBTK*+MUP database shows no divergence of the number of correct assignments and thus no apparent advantage compared to the commercial MBTK database. However, using the MBTK*+MUP database, a moderately higher mean score value was obtained for the validation spectra set used (2.36 vs 2.46).

No divergent identifications were observed for other species of the genus Corynebacterium (n = 37), other Actinomycetota species (n = 57), or even more distantly related microorganisms (n = 750) included in the validation data set (Table 2).

Overall, C. diphtheriae, C. pseudotuberculosis, C. silvaticum, and C. ulcerans can be reported as validated parameters in our accredited laboratories for official veterinary diagnostics. This achievement is based on the fulfillment of all requirements of the extended reference spectra collection (MBTK* +MUP) and the validation procedure according to specified formal criteria of the BVL technical guidelines (47). For C. belfantii, C. ramonii, and C. rouxii, the prospects of differentiation are promising although the number of available spectra for isolates of these species is still too small for a complete formal validation.

For all the seven species of the CdSC, we propose identification hints using the commercial MBTK database to guide the user and to avoid erroneous interpretation of the results (Table 3).

Using the MBTK*+MUP database, the identification of species not belonging to the CdSC is enhanced significantly (Tables 2 and 5). In this case, the identification rate of the control group increases from 47.3% for all isolate spectra (n = 1,529) using the commercial MBTK database to 76.6% using the custom MBTK*+MUP database (e.g., Table S3e vs Table S4e). Therefore, we conclude that regular database updates are necessary to ensure a comprehensive, efficient, and consistent up-to-date identification. Subsequently, the custom MBTK*+MUP database was in use for first specific studies (10).

As previously demonstrated, the user-driven exchange of custom entries accessible on MUP serves as an effective approach for a vast expansion of in-house identifications, complementing the periodic updates of the commercial database (48). The availability of open access catalogs, like MUP, facilitates a global inter-laboratory exchange of spectra. Moreover, the option of downloading spectra collections, such as the RKI database, enables users to freely access and provide data for a broad scientific community (65, 66). Finally, successful validation can be performed based on a broad collection of well-documented MALDI-TOF MS single spectra to reduce the workload for each single laboratory (47, 48).

Conclusions and prospects

MALDI-TOF MS has become an indispensable tool for a fast and reliable identification of bacteria at the species level in many diagnostic laboratories. However, a sophisticated and up-to-date database is necessary for the exact identification of closely related bacterial species according to current taxonomy, as here demonstrated for the valid species of the CdSC. Thus, database users should be aware of possible performance flaws with ongoing taxonomic changes. Consequently, the identification of bacteria according to the current taxonomy is the basis of treatment of human and animal infections, risk assessment, and the implementation of preventive measures such as vaccination programs.

Using CdSC as an example, here we show for the first time taking into account current guideline, how to keep up with the latest taxonomic assignments of bacteria by modifying and extending a current commercial database with own and exchanged MSPs. In this regard, the globally free accessible MALDI-UP catalog for user created reference and validation spectra was utilized and the employed validation process used in this study fulfills the required number of isolates in accordance with the applied guidelines (47). This approach to the identification of very closely related bacterial species with recent taxonomic changes using MALDI-TOF MS can certainly be used as a blueprint for other sophisticated bacterial identifications in order to react to complex species identifications of interest in a short time frame. Using appropriate methods, AI could support the manual evaluation of spectra and data in the future, to reduce the formal validation effort shown here.

Highlights

  • Using MALDI-TOF MS, all species of the C. diphtheriae species complex are accurately identified according to the current taxonomy in order to adequately address the requirements of epidemiology and zoonosis control

  • Validation was performed using spectra from different institutions and an approved standard protocol

  • The expansion and the exchange of user created reference spectra via the MALDI User Platform are proved to be a key tool for precise identification of bacteria

ACKNOWLEDGMENTS

We thank Vanessa Nowak, Sabine Lohrer, Jasmin Scholz, Marion Lindermayer, Anne Könitzer, Wolfgang Schmidt, Helga Kocak, Juliane Breitenberger, Andrea Seifarth, Juliana Webersberger and Turgut-Cengiz Dedeoglu for expert technical assistance.

This work was supported by the Bavarian State Ministry of Health, Care, and Prevention and by the German Federal Ministry of Health through the Robert Koch Institute and its National Reference Laboratories Network (grant no. FKZ 1369-359) to the German National Consiliary Laboratory for Diphtheria.

Contributor Information

Jörg Rau, Email: joerg.rau@cvuas.bwl.de.

Barbara A. Byrne, University of California, Davis, Davis, California, USA

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/jcm.01324-25.

Table S1. jcm.01324-25-s0001.xlsx.

MALDI - Validation Spectra.

jcm.01324-25-s0001.xlsx (914.5KB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF1
Table S2. jcm.01324-25-s0002.xlsx.

Corynebacterium Reference Genomes.

jcm.01324-25-s0002.xlsx (28.3KB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF2
Tables S3a-S3i. jcm.01324-25-s0003.xlsx.

Reports of Validation_targeted-ID_MBTk (11897).

jcm.01324-25-s0003.xlsx (1.7MB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF3
Tables S4a-S4f. jcm.01324-25-s0004.xlsx.

Reports of Validation_targeted-ID_MBTk_MUP (13370).

jcm.01324-25-s0004.xlsx (1.3MB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF4
Figure S1. jcm.01324-25-s0005.pdf.

Heatmap showing the average nucleotide identity (ANI) analysis of 184 Corynebacterium isolates.

jcm.01324-25-s0005.pdf (68.1KB, pdf)
DOI: 10.1128/jcm.01324-25.SuF5
Supplemental legends. jcm.01324-25-s0006.docx.

Legends for Tables S1, S2, S3a-i, S4a-f, and Figure S1.

jcm.01324-25-s0006.docx (41.8KB, docx)
DOI: 10.1128/jcm.01324-25.SuF6

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Gant MS, Chamot-Rooke J. 2024. Present and future perspectives on mass spectrometry for clinical microbiology. Microbes Infect 26:105296. doi: 10.1016/j.micinf.2024.105296 [DOI] [PubMed] [Google Scholar]
  • 2. Thompson JE. 2022. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in veterinary medicine: recent advances (2019-present). Vet World 15:2623–2657. doi: 10.14202/vetworld.2022.2623-2657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Malorny B, Scheel K, Rau J, Beyer W, Buschulte A, Nöckler K, Kreienbrock L. 2020. Onlineumfrage zur Anwendung von molekularbiologischen Typisierungsverfahren und MALDI-TOF-MS in diagnostischen Laboren in Deutschland. J Consum Prot Food Saf 15:387–391. doi: 10.1007/s00003-020-01297-8 [DOI] [Google Scholar]
  • 4. European Centre for Disease Prevention and Control (ECDC) . 2024. Diphtheria. In Annual epidemiological report for 2022. ECDC, Stockholm. https://www.ecdc.europa.eu/sites/default/files/documents/DIPH_AER_2022_report.pdf. [Google Scholar]
  • 5. EU-Commission . 2018. COMMISSION IMPLEMENTING DECISION (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union. https://eur-lex.europa.eu/eli/dec_impl/2018/945/oj/eng. [Google Scholar]
  • 6. Hoefer A, Seth-Smith H, Palma F, Schindler S, Freschi L, Dangel A, Berger A, D’Aeth J, Cordery R, Delgado-Rodriguez E, et al. 2025. Corynebacterium diphtheriae outbreak in migrant populations in Europe. N Engl J Med 392:2334–2345. doi: 10.1056/NEJMoa2311981 [DOI] [PubMed] [Google Scholar]
  • 7. Lehmann KB, Neumann R. 1886. Atlas und Grundriss der Bakteriologie und Lehrbuch der speziellen bakteriologischen Diagnostik. 1st ed. Munich, Germany. [Google Scholar]
  • 8. Bartlett A, Padfield D, Lear L, Bendall R, Vos M. 2022. A comprehensive list of bacterial pathogens infecting humans. Microbiology (Reading) 168:12. doi: 10.1099/mic.0.001269 [DOI] [PubMed] [Google Scholar]
  • 9. Prygiel M, Polak M, Mosiej E, Wdowiak K, Formińska K, Zasada AA. 2022. New Corynebacterium species with the potential to produce diphtheria toxin. Pathogens 11:1264. doi: 10.3390/pathogens11111264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Walter B, Lück K, Adam M, Winter B, Rau J, Knab N, Welker A, Aichinger E, Brockmann S. 2025. A cross-sectional study on diphtheria and other wound infections among asylum seekers arriving in Baden-Wuerttemberg, Germany, August – October 2024. Poster. ESCMID 11.-15. April 2025. [Google Scholar]
  • 11. Tagini F, Pillonel T, Croxatto A, Bertelli C, Koutsokera A, Lovis A, Greub G. 2018. Distinct genomic features characterize two clades of Corynebacterium diphtheriae: proposal of Corynebacterium diphtheriae subsp. diphtheriae subsp. nov. and Corynebacterium diphtheriae subsp. lausannense subsp. nov. Front Microbiol 9:1743. doi: 10.3389/fmicb.2018.01743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Dazas M, Badell E, Carmi-Leroy A, Criscuolo A, Brisse S. 2018. Taxonomic status of Corynebacterium diphtheriae biovar Belfanti and proposal of Corynebacterium belfantii sp. nov. Int J Syst Evol Microbiol 68:3826–3831. doi: 10.1099/ijsem.0.003069 [DOI] [PubMed] [Google Scholar]
  • 13. Badell E, Hennart M, Rodrigues C, Passet V, Dazas M, Panunzi L, Bouchez V, Carmi-Leroy A, Toubiana J, Brisse S. 2020. Corynebacterium rouxii sp. nov., a novel member of the diphtheriae species complex. Res Microbiol 171:122–127. doi: 10.1016/j.resmic.2020.02.003 [DOI] [PubMed] [Google Scholar]
  • 14. Schlez K, Eisenberg T, Rau J, Dubielzig S, Kornmayer M, Wolf G, Berger A, Dangel A, Hoffmann C, Ewers C, Sing A. 2021. Corynebacterium rouxii, a recently described member of the C. diphtheriae group isolated from three dogs with ulcerative skin lesions. Antonie Van Leeuwenhoek 114:1361–1371. doi: 10.1007/s10482-021-01605-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Sing A, Dangel A, Konrad R, Meinel DM, Schwabe I, Sting R, Rau J, Berger A. 2025. Corynebacterium rouxii in a free-roaming red fox: case report and historical review on diphtheria in animals. Infection 53:1253–1258. doi: 10.1007/s15010-025-02515-x [DOI] [PubMed] [Google Scholar]
  • 16. Riegel P, Ruimy R, de Briel D, Prévost G, Jehl F, Christen R, Monteil H. 1995. Taxonomy of Corynebacterium diphtheriae and related taxa, with recognition of Corynebacterium ulcerans sp. nov. nom. rev. FEMS Microbiol Lett 126:271–276. doi: 10.1111/j.1574-6968.1995.tb07429.x [DOI] [PubMed] [Google Scholar]
  • 17. Berger A, Dangel A, Peters M, Mühldorfer K, Braune S, Eisenberg T, Szentiks CA, Rau J, Konrad R, Hörmansdorfer S, Ackermann N, Sing A. 2019. Tox-positive Corynebacterium ulcerans in hedgehogs, Germany. Emerging Microbes and Infection 8:211–217. doi: 10.1080/22221751.2018.1562312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hillan A, Gibbs T, Weaire-Buchanan G, Brown T, Pang S, McEvoy SP, Parker E. 2024. Zoonotic transmission of diphtheria toxin-producing Corynebacterium ulcerans. Zoonoses Public Health 71:157–169. doi: 10.1111/zph.13094 [DOI] [PubMed] [Google Scholar]
  • 19. Eisenberg T, Mauder N, Contzen M, Rau J, Ewers C, Schlez K, Althoff G, Schauerte N, Geiger C, Margos G, Konrad R, Sing A. 2015. Outbreak with clonally related isolates of Corynebacterium ulcerans in a group of water rats. BMC Microbiol 15:42. doi: 10.1186/s12866-015-0384-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Grönthal TSC, Lehto AK, Aarnio SS, Eskola EK, Aimo-Koivisto EM, Karlsson T, Koskinen HI, Barkoff A-M, He Q, Lienemann T, Rimhanen-Finne R, Mykkänen A. 2024. Pastern dermatitis outbreak associated with toxigenic and non-toxigenic Corynebacterium diphtheriae and non-toxigenic Corynebacterium ulcerans at a horse stable in Finland, 2021. Zoonoses Public Health 71:127–135. doi: 10.1111/zph.13090 [DOI] [PubMed] [Google Scholar]
  • 21. Sting R, Pölzelbauer C, Eisenberg T, Bonke R, Blazey B, Peters M, Riße K, Sing A, Berger A, Dangel A, Rau J. 2023. Corynebacterium ulcerans infections in Eurasian Beavers (Castor fiber). Pathogens 12:979. doi: 10.3390/pathogens12080979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Martel A, Boyen F, Rau J, Eisenberg T, Sing A, Berger A, Chiers K, Van Praet S, Verbanck S, Vervaeke M, Pasmans F. 2021. Widespread disease in hedgehogs (Erinaceus europaeus) caused by toxigenic Corynebacterium ulcerans. Emerg Infect Dis 27:2686–2690. doi: 10.3201/eid2710.203335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Thomas A, Slifka AM, Hendrickson SM, Amanna IJ, Slifka MK. 2022. Active circulation of Corynebacterium ulcerans among nonhuman primates. Microbiol Spectr 10:e0089422. doi: 10.1128/spectrum.00894-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Wang H, Wang X, Cao Y, Chen Y, Zou Z, Lu X, Shan F, Tu J, Liu J, Liu J, Sa J, Zhou N, Peng S-M, Zou J-J, Shen X, Zhai J, Chen Z, Holmes EC, Chen W, Shen Y. 2024. Identification of Corynebacterium ulcerans and Erysipelothrix sp. in Malayan pangolins-a potential threat to public health? mSphere 9:e0055124. doi: 10.1128/msphere.00551-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Meinel DM, Margos G, Konrad R, Krebs S, Blum H, Sing A. 2014. Next generation sequencing analysis of nine Corynebacterium ulcerans isolates reveals zoonotic transmission and a novel putative diphtheria toxin-encoding pathogenicity island. Genome Med 6:113. doi: 10.1186/s13073-014-0113-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Otsuji K, Fukuda K, Endo T, Shimizu S, Harayama N, Ogawa M, Yamamoto A, Umeda K, Umata T, Seki H, Iwaki M, Kamochi M, Saito M. 2017. The first fatal case of Corynebacterium ulcerans infection in Japan. JMM Case Rep 4:e005106. doi: 10.1099/jmmcr.0.005106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Slinko VG, Guglielmino CJ, Uren AM, Smith JK, Neucom D, Smoll NR, Graham RM, Fang N-X, Smith HV, Armstrong AE, Kenny AA, Farmer JL, Quagliotto CA, Jennison AV. 2023. Several confirmed and probable zoonotic cases of toxigenic Corynebacterium ulcerans, Queensland, Australia. Commun Dis Intell (2018) 47. doi: 10.33321/cdi.2023.47.53 [DOI] [PubMed] [Google Scholar]
  • 28. Dangel A, Berger A, Rau J, Eisenberg T, Kämpfer P, Margos G, Contzen M, Busse H-J, Konrad R, Peters M, Sting R, Sing A. 2020. Corynebacterium silvaticum sp. nov., a unique group of NTTB corynebacteria in wild boar and roe deer. Int J Syst Evol Microbiol 70:3614–3624. doi: 10.1099/ijsem.0.004195 [DOI] [PubMed] [Google Scholar]
  • 29. Contzen M, Sting R, Blazey B, Rau J. 2011. Corynebacterium ulcerans from diseased wild boars carrying Corynebacterium diphtheriae-like tox genes. Zoon Publ Health 58. doi: 10.1111/j.1863-2378.2011.01396.x [DOI] [PubMed] [Google Scholar]
  • 30. Rau J, Blazey B, Contzen M, Sting R. 2012. Corynebacterium ulcerans-Infektion bei einem Reh (Capreolus capreolus). Berliner und Münchener Tierärztliche Wochenschrift 125:159–162. [PubMed] [Google Scholar]
  • 31. Eisenberg T, Contzen M, Kutzer P, Peters M, Sing A, Rau J. 2014. Non toxigenic tox-bearing Corynebacterium ulcerans infection in game in Germany. Emerging Infection Diseases 20:448–452. doi: 10.3201/eid2003.130423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Viana MVC, Galdino JH, Profeta R, Oliveira M, Tavares L, de Castro Soares S, Carneiro P, Wattam AR, Azevedo V. 2023. Analysis of Corynebacterium silvaticum genomes from Portugal reveals a single cluster and a clade suggested to produce diphtheria toxin. PeerJ 11:e14895. doi: 10.7717/peerj.14895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Berger A, Dangel A, Melnikov VG, Bengs K, Rupp T, Mappes HJ, Schneider C, Sing A. 2025. Human infections by novel zoonotic species Corynebacterium silvaticum, Germany. Emerg Infect Dis 31:1450–1454. doi: 10.3201/eid3107.250086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Crestani C, Arcari G, Landier A, Passet V, Garnier D, Brémont S, Armatys N, Carmi-Leroy A, Toubiana J, Badell E, Brisse S. 2023. Corynebacterium ramonii sp. nov., a novel toxigenic member of the Corynebacterium diphtheriae species complex. Res Microbiol 174:104113. doi: 10.1016/j.resmic.2023.104113 [DOI] [PubMed] [Google Scholar]
  • 35. Shitada C, Moriguchi M, Hayashi H, Matsumoto K, Mori M, Tokuoka E, Yahiro S, Gejima S, Horiba K, Yamamoto T, Takahashi M, Kuroda M. 2024. Genomic analysis of novel bacterial species Corynebacterium ramonii ST344 clone strains isolated from human skin ulcer and rescued cats in Japan. Zoonotic Diseases 4:234–244. doi: 10.3390/zoonoticdis4040020 [DOI] [Google Scholar]
  • 36. Lowe CF, Ritchie G, Crestani C, Imperial M, Matic N, Payne M, Stefanovic A, Whellams D, Brisse S, Romney MG. 2025. Diphtheria toxin-producing Corynebacterium ramonii in inner-city population, Vancouver, British Columbia, Canada, 2019-2023. Emerg Infect Dis 31:323–327. doi: 10.3201/eid3102.241472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Eberson FA 1. 1918. A bacteriologic study of the diphtheroid organisms with special reference to hodgkin’s disease. J Infect Dis 23:1–42. doi: 10.1086/infdis/23.1.1 [DOI] [Google Scholar]
  • 38. Domenis L, Spedicato R, Orusa R, Goria M, Sant S, Guidetti C, Robetto S. 2017. The diagnostic activity on wild animals through the description of a model case report (caseous lymphadenitis by Corynebacterium pseudotuberculosis associated with Pasteurella spp and parasites infection in an alpine ibex - Capra ibex). Open Vet J 7:384–390. doi: 10.4314/ovj.v7i4.15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Domenis L, Spedicato R, Pepe E, Orusa R, Robetto S. 2018. Caseous lymphadenitis caused by Corynebacterium pseudotuberculosis in Alpine Chamois (Rupicapra r. rupicapra): a review of 98 cases. J Comp Pathol 161:11–19. doi: 10.1016/j.jcpa.2018.04.003 [DOI] [PubMed] [Google Scholar]
  • 40. Sting R, Rietschel W, Polley B, Süß-Dombrowski C, Rau J. 2017. Corynebacterium pseudotuberculosis infection in a dromedary (Camelus dromedarius) in Germany. Berliner und Münchener Tierärztliche Wochenschrift 130:511–516. https://vetline.de/corynebacterium-pseudotuberculosis-infection-in-a-dromedary-camelus-dromedarius-in-germany/150/3130/105368. [Google Scholar]
  • 41. Sting R, Geiger C, Rietschel W, Blazey B, Schwabe I, Rau J, Schneider-Bühl L. 2022. Corynebacterium pseudotuberculosis infections in Alpacas (Vicugna pacos). Animals (Basel) 12:1612. doi: 10.3390/ani12131612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Hiller E, Hörz V, Sting R. 2024. Corynebacterium pseudotuberculosis: Whole genome sequencing reveals unforeseen and relevant genetic diversity in this pathogen. PLoS One 19:e0309282. doi: 10.1371/journal.pone.0309282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Miers KC, Ley WB. 1980. Corynebacterium pseudotuberculosis infection in the horse: study of 117 clinical cases and consideration of etiopathogenesis. J Am Vet Med Assoc 177:250–253. doi: 10.2460/javma.1980.177.03.250 [DOI] [PubMed] [Google Scholar]
  • 44. Selim SA. 2001. Oedematous skin disease of buffalo in Egypt. J Vet Med B 48:241–258. doi: 10.1046/j.1439-0450.2001.00451.x [DOI] [PubMed] [Google Scholar]
  • 45. Bregenzer T, Frei R, Ohnacker H, Zimmerli W. 1997. Corynebacterium pseudotuberculosis infection in a butcher. Clin Microbiol Infect 3:696–698. doi: 10.1111/j.1469-0691.1997.tb00482.x [DOI] [PubMed] [Google Scholar]
  • 46. Peel MM, Palmer GG, Stacpoole AM, Kerr TG. 1997. Human lymphadenitis due to Corynebacterium pseudotuberculosis: report of ten cases from Australia and review. Clin Infect Dis 24:185–191. doi: 10.1093/clinids/24.2.185 [DOI] [PubMed] [Google Scholar]
  • 47. BVL . 2022. Federal office of consumer protection and food safety: guidelines for validating species identifications using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) in a single laboratory or in laboratory networks. https://www.bvl.bund.de/SharedDocs/Downloads/07_Untersuchungen/ Guidelines_for_validating_species_identifications_using_MALDI-TOF-MS.pdf;jsessionid=385A5C363D8718FF3D44B0A04694F886.2_cid372?__blob=publicationFile&v=4.
  • 48. Rau Jörg, Etter D, Frentzel H, Lasch P, Contzen M. 2025. Reliable delineation of Bacillus cytotoxicus from other members of the Bacillus cereus group by MALDI-TOF MS – An extensive validation study. Food Control 167:110825. doi: 10.1016/j.foodcont.2024.110825 [DOI] [Google Scholar]
  • 49. Oberreuter H, Dyk M, Rau J. 2023. Validated differentiation of Listeria monocytogenes serogroups by FTIR spectroscopy using an artificial neural network based classifier in an accredited official food control laboratory. Clinical Spectroscopy 5:100030. doi: 10.1016/j.clispe.2023.100030 [DOI] [Google Scholar]
  • 50. Rau J, Eisenberg T, Peters M, Berger A, Kutzer P, Lassnig H, Hotzel H, Sing A, Sting R, Contzen M. 2019. Reliable differentiation of a non-toxigenic tox gene-bearing Corynebacterium ulcerans variant frequently isolated from game animals using MALDI-TOF MS. Vet Microbiol 237:108399. doi: 10.1016/j.vetmic.2019.108399 [DOI] [PubMed] [Google Scholar]
  • 51. Melnikov VG, Berger A, Sing A. 2022. Detection of diphtheria toxin production by toxigenic corynebacteria using an optimized Elek test. Infection 50:1591–1595. doi: 10.1007/s15010-022-01903-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Melnikov VG, Berger A, Dangel A, Sing A. 2023. Lateral flow immunoassay-based laboratory algorithm for rapid diagnosis of diphtheria. Open Res Eur 3:62. doi: 10.12688/openreseurope.15038.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Schuhegger R, Lindermayer M, Kugler R, Heesemann J, Busch U, Sing A. 2008. Detection of toxigenic Corynebacterium diphtheriae and Corynebacterium ulcerans strains by a novel real-time PCR. J Clin Microbiol 46:2822–2823. doi: 10.1128/JCM.01010-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Barksdale L, Linder R, Sulea IT, Pollice M. 1981. Phospholipase D activity of Corynebacterium pseudotuberculosis (Corynebacterium ovis) and Corynebacterium ulcerans, a distinctive marker within the genus Corynebacterium. J Clin Microbiol 13:335–343. doi: 10.1128/jcm.13.2.335-343.1981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Deneke C, Brendebach H, Uelze L, Borowiak M, Malorny B, Tausch SH. 2021. Species-specific quality control, assembly and contamination detection in microbial isolate sequences with AQUAMIS. Genes (Basel) 12:644. doi: 10.3390/genes12050644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, Tiedje JM. 2007. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol 57:81–91. doi: 10.1099/ijs.0.64483-0 [DOI] [PubMed] [Google Scholar]
  • 57. Nouioui I, Carro L, García-López M, Meier-Kolthoff JP, Woyke T, Kyrpides NC, Pukall R, Klenk HP, Goodfellow M, Göker M. 2018. Genome-based taxonomic classification of the phylum Actinobacteria. Front Microbiol 9:2007. doi: 10.3389/fmicb.2018.02007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Rau J, Eisenberg T, Männig A, Wind C, Lasch P, Sting R. 2016. MALDI-UP – an internet platform for the exchange of mass spectra – user guide for https://MALDI-UP.ua-bw.de. Aspects of Food Control and Animal Health 1:1–17. [Google Scholar]
  • 59. Pranada BP, Schwarz G, Kostrzewa M. 2016. MALDI Biotyping for microorganism identification in clinical microbiology, p 197–222. In Advances in MALDI and Laser-induced soft ionization mass spectrometry. Springer International Publishing, Switzerland. 10.1007/978-3-319-04819-2_11. [DOI] [Google Scholar]
  • 60. Kostrzewa M, Maier T. 2017. Criteria for development of MALDI-TOF mass spectral database. In H.N. Shah, S.E. Gharbia (Eds.) (ed), MALDI-TOF and Tandem MS for clinical microbiology. John Wiley & Sons Ltd, Hoboken, USA. [Google Scholar]
  • 61. Lasch P, Nattermann H, Erhard M, Stämmler M, Grunow R, Bannert N, Appel B, Naumann D. 2008. MALDI-TOF mass spectrometry compatible inactivation method for highly pathogenic microbial cells and spores. Anal Chem 80:2026–2034. doi: 10.1021/ac701822j [DOI] [PubMed] [Google Scholar]
  • 62. Bruker . 2022. Product information - Release Notes. MBT Compass Library Revision K. [Google Scholar]
  • 63. Rau J, Eisenberg T, Wind C, Huber I, Pavlovic M, Becker R. 2022. Aus der § 64 LFGB-arbeitsgruppe MALDI-TOF: Leitlinien für die Validierung von Spezies-Identifizierungen mittels MALDI-TOF-MS. J Consum Prot Food Saf 17:97–101. doi: 10.1007/s00003-021-01353-x [DOI] [Google Scholar]
  • 64. Timofte D, Overesch G, Spergser J. 2023. MALDI-TOF MS analysis for identification of veterinary pathogens from companion animals and livestock species. In Shan HN, Gharbia SE (ed), Microbiological identification using MALDI-TOF and tandem mass spectrometry: Industrial and environmental applications. Wiley. [Google Scholar]
  • 65. Lasch P, Beyer W, Bosch A, Borriss R, Drevinek M, Dupke S, Ehling-Schulz M, Gao X, Grunow R, Jacob D, Klee SR, Paauw A, Rau J, Schneider A, Scholz HC, Stämmler M, Thanh Tam LT, Tomaso H, Werner G, Doellinger J. 2025. A MALDI-ToF mass spectrometry database for identification and classification of highly pathogenic bacteria. Sci Data 12:187. doi: 10.1038/s41597-025-04504-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. CVUAS . 2015. Chemisches und Veterinäruntersuchungsamt Stuttgart: MALDI-TOF MS user platform MALDI-UP. Available from: https://www.maldi-up.ua-bw.de. Retrieved 10 Feb 2025.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1. jcm.01324-25-s0001.xlsx.

MALDI - Validation Spectra.

jcm.01324-25-s0001.xlsx (914.5KB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF1
Table S2. jcm.01324-25-s0002.xlsx.

Corynebacterium Reference Genomes.

jcm.01324-25-s0002.xlsx (28.3KB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF2
Tables S3a-S3i. jcm.01324-25-s0003.xlsx.

Reports of Validation_targeted-ID_MBTk (11897).

jcm.01324-25-s0003.xlsx (1.7MB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF3
Tables S4a-S4f. jcm.01324-25-s0004.xlsx.

Reports of Validation_targeted-ID_MBTk_MUP (13370).

jcm.01324-25-s0004.xlsx (1.3MB, xlsx)
DOI: 10.1128/jcm.01324-25.SuF4
Figure S1. jcm.01324-25-s0005.pdf.

Heatmap showing the average nucleotide identity (ANI) analysis of 184 Corynebacterium isolates.

jcm.01324-25-s0005.pdf (68.1KB, pdf)
DOI: 10.1128/jcm.01324-25.SuF5
Supplemental legends. jcm.01324-25-s0006.docx.

Legends for Tables S1, S2, S3a-i, S4a-f, and Figure S1.

jcm.01324-25-s0006.docx (41.8KB, docx)
DOI: 10.1128/jcm.01324-25.SuF6

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES